Theragenics® operates two business segments: Surgical Products and Brachytherapy.
Surgical Products manufactures and distributes wound closure, vascular access, and specialty needle products. Wound closure products include sutures, needles and other surgical products. Vascular access includes introducers, valved sheaths, guidewires and related products. Specialty needles include coaxial, biopsy, spinal and disposable veress needles, access trocars, and other needle-based products. Our Surgical segment serves a number of markets and applications, including interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental, urology, veterinary, pain management, endoscopy, and spine.
Brachytherapy manufactures and markets the palladium-103 TheraSeed® and iodine-125 AgX100® devices. These devices are primarily used to treat patients with localized prostate cancer in a one-time minimally invasive procedure. Our Brachytherapy segment also manufactures and markets seeds in mesh, flexible packaging for the treatment of organ-confined localized cancer and seeds in eye plaques for treatment of ocular melanoma.
Theragenics and its subsidiaries have five manufacturing facilities:
- Our headquarters, and our brachytherapy business, are located in Buford, Georgia.
- Our CP Medical subsidiary is located in Norcross, Georgia.
- Our Galt Medical facilities are located in Alajuela, Costa Rica and Garland, Texas.
- Our NeedleTech subsidiary is located in North Attleboro, Massachusetts.